VE-cadherin can be a target for proteolytic cleavage by serine proteases [33] and the extracellular domain of VE-cadherin (“soluble” VE-cadherin, sVE-cadherin) can be found in patients with inflammatory diseases like rheumatoid arthritis [34]. Here, CDH5 is linked to rheumatoid arthritis.